Linda Bech
About Linda Bech
Linda Bech is the Manager, Head of Patient Safety, DK & IS at Bristol Myers Squibb, specializing in pharmacovigilance with a background in health promotion, socio-economic planning, and nutrition.
Company
Linda Bech is currently employed at Bristol Myers Squibb, a leading global biopharmaceutical company. She serves as the Manager, Head of Patient Safety for Denmark and Iceland, operating from København og omegn. Bristol Myers Squibb focuses on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Linda Bech holds the position of Manager, Head of Patient Safety for Denmark and Iceland at Bristol Myers Squibb. Her role involves the oversight of patient safety activities, ensuring compliance with regulatory requirements and enhancing the safety of pharmaceutical products in these regions.
Education and Expertise
Linda Bech completed her Master of Science (M.Sc.) in Health Promotion and Health Strategies/Technology and Socio-Economic Planning at Roskilde Universitetscenter from 2011 to 2013. She also holds a Bachelor's degree in Nutrition and Health, specializing in Product Development, from Professionshøjskolen Metropol, Ernæring og Sundhed, where she studied from 2007 to 2011. Her educational background supports her expertise in pharmacovigilance, patient safety, and health product development.
Previous Experience
Before her current role, Linda Bech held various positions at Bristol Myers Squibb, including Manager, Head of Patient Safety for Denmark, and Head of Country Pharmacovigilance (Denmark). She has also worked at Lindeq as a Drug Safety Manager, Novo Nordisk as a Regulatory Associate Temp., Actavis as a Pharmacovigilance Associate in Compliance, and Takeda Pharmaceuticals as a Student Assistant in the International Drug Safety Department.
Background in Pharmacovigilance
Linda Bech specializes in pharmacovigilance within the pharmaceutical industry. Her responsibilities have encompassed drug safety management, regulatory compliance, and international drug safety. Her background includes experience in both health promotion and socio-economic planning, as well as nutrition and health product development, providing a multidisciplinary approach to patient safety and pharmacovigilance.